The management of chronic pain in important patient subgroups

Clinical Drug Investigation

Volumn 32, Issue SUPPL. 1, 2012, Pages 35-44

  Cherubino, Paolo ^a   Sarzi Puttini, Piercarlo ^b   Zuccaro, Stefano Maria ^c   Labianca, Roberto ^d  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Piazza San Bartolomeo All'Isola 21   (Italy)

^d OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; DULOXETINE; FLUOXETINE; HYDROMORPHONE; MILNACIPRAN; MOCLOBEMIDE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; PIRLINDOLE; PRAMIPEXOLE; PREGABALIN; TRAMADOL; TROPISETRON; VINCRISTINE; ANALGESIC AGENT; NARCOTIC ANALGESIC AGENT;

AGING; ANALGESIA; ANXIETY; CANCER PAIN; CHONDROPATHY; CHRONIC PAIN; DAILY LIFE ACTIVITY; DEPRESSION; EMPLOYMENT STATUS; FIBROMYALGIA; HIGH RISK PATIENT; HUMAN; INJURY; MIGRAINE; NERVE INJURY; NEUROPATHIC PAIN; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SPINE FRACTURE; WHIPLASH INJURY; AGED; COMPLICATION; EUROPE; NEOPLASMS; QUALITY OF LIFE;

AGING; ANALGESICS, OPIOID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC PAIN; HUMANS; PAIN MANAGEMENT; PAIN MEASUREMENT; ACTIVITIES OF DAILY LIVING; AGED; ANALGESICS; ANXIETY; DEPRESSION; EUROPE; NEOPLASMS; QUALITY OF LIFE;

EID: 84857589892     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11630060-000000000-00000     Document Type: Review

References (56)

1. Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006;10(4):287-333
2. Reid KJ, Harker J, Bala MM, et al. Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Curr Med Res Opin 2011;27(2):449-62
3. Kumar N. WHO Normative Guidelines on Pain Management. Geneva: World Health Organization, 2007 June
4. Pogatzki-Zahn EM, Englbrecht JS, Schug SA. Acute pain management in patients with fibromyalgia and other diffuse chronic pain syndromes. Curr Opin Anaesthesiol 2009;22(5):627-33
5. Vellucci R. Heterogeneity ofchromic pain. Clin Drug Investig 2012;32(Suppl. 1):3-10
6. Fornasari D. Pain mechanisms in patients with chronic pain. Clin Drug Investig 2012;32(Suppl. 1):45-52
7. Institute for Clinical Systems Improvement (ICSI). Health Care Guideline: Assessment and Management of Chronic Pain (fourth edition) 2009: Available from: www.icsi.org
8. Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000;59(12):936-44
9. Carville SF, Arendt-Nielsen S, Bliddal H, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008;67(4):536-41 (Pubitemid 351498437)
10. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62(5):600-10
11. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 2002;46(2):328-346
12. National Collaborating Centre for Chronic Conditions. Osteoarthritis: national clinical guideline for care and management in adults 2008: Available from: http://guidance.nice.org.uk/CG59/Guidance/
13. National Collaborating Centre for Chronic Conditions. Rheumatoid arthritis: national clinical guideline for management and treatment in adults 2009: Available from: http://guidance.nice.org.uk/CG79/Guidance/
14. Herndon CM, Hutchison RW, Berdine HJ, et al. Management of chronic nonmalignant pain with nonsteroidal antiinflammatory drugs. Joint opinion statement of the Ambulatory Care, Cardiology, and Pain and Palliative Care Practice and Research Networks of the American College of Clinical Pharmacy. Pharmacotherapy 2008;28(6):788-805 (Pubitemid 351975382)
15. Combe B, Landewe R, Lukas C, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66(1):34-45 (Pubitemid 46044858)
16. Schnitzer TJ. Update on guidelines for the treatment of chronic musculoskeletal pain. Clin Rheumatol 2006;25 Suppl. 1:S22-9 (Pubitemid 43933679)
17. Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005;64(5):669-81 (Pubitemid 40559291)
18. Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66(3):377-88 (Pubitemid 46579641)
19. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16(2):137-62 (Pubitemid 351222155)
20. Ng SC, Chan FK. NSAID-induced gastrointestinal and cardiovascular injury. Curr Opin Gastroenterol 2010;26(6):611-17
21. Garcia Rodriguez LA, Gonzalez-Perez A, Bueno H, et al. NSAID use selectively increases the risk of non-fatal myocardial infarction: a systematic review of randomised trials and observational studies. PLoS One 2011;6(2): e16780
22. Trelle S, Reichenbach S, Wandel S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011;342:c7086
23. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10(2):113-30
24. Whittle SL, Richards BL, Husni E, et al. Opioid therapy for treating rheumatoid arthritis pain. Cochrane Database Syst Rev 2011;11:CD003113
25. Lang LJ, Pierer M, Stein C, et al. Opioids in rheumatic diseases. Ann N Y Acad Sci 2010;1193:111-16
26. Podichetty VK, Mazanec DJ, Biscup RS. Chronic nonmalignant musculoskeletal pain in older adults: clinical issues and opioid intervention. Postgrad Med J 2003;79(937):627-33 (Pubitemid 38019212)
27. Furlan AD, Sandoval JA, Mailis-Gagnon A, et al. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006;174(11):1589-94 (Pubitemid 43829515)
28. Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs 2003;63(1):17-32 (Pubitemid 36132511)
29. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 2005;293(24):3043-52 (Pubitemid 40965075)
30. Lawson K. Treatment options and patient perspectives in the management of fibromyalgia: future trends. Neuropsychiatr Dis Treat 2008;4(6):1059-71
31. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004;292(19):2388-95 (Pubitemid 39491924)
32. Sommer C. Fibromyalgia: A Clinical Update. Pain: Clinical Updates, 2010; XVIII (4):1-4
33. Schneider P, Farahati J, Reiners C. Radiosynovectomy in rheumatology, orthopedics, and hemophilia. J Nucl Med 2005;46 Suppl. 1:48S-54S (Pubitemid 47619018)
34. American Geriatric Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009;57(8):1331-46
35. Colson J, Koyyalagunta D, Falco FJ, et al. A systematic review of observational studies on the effectiveness of opioid therapy for cancer pain. Pain Physician 2011;14(2):E85-102
36. National Institutes of Health. NIH State-of-the-Science Statement on symptom management in cancer: pain, depression, and fatigue. NIH Consens State Sci Statements 2002;19(4):1-29
37. Herr KA, Garand L. Assessment and measurement of pain in older adults. Clin Geriatr Med 2001;17(3):457-78, vi (Pubitemid 32783030)
38. World Health Organization. National Cancer Control Programmes: Policies and managerial guidelines. 2nd Edition 2002: Available from: http://www.who.int/cancer/media/en/408.pdf
39. Breivik H, Cherny N, Collett B, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 2009;20(8):1420-33
40. Deandrea S, Montanari M, Moja L, et al. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 2008;19(12):1985-91
41. Raphael J, Ahmedzai S, Hester J, et al. Cancer pain: part 1: Pathophysiology; oncological, pharmacological, and psychological treatments: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Med 2010;11(5):742-64
42. National Comprehensive Cancer Network. NCCN Practice Guidelines in Oncology: Adult Cancer Pain, Version I. [Online] 2011; Available from: http://www.nccn.org/professionals/physician-gls/pdf/pain.pdf
43. Regan JM, Peng P. Neurophysiology of cancer pain. Cancer Control 2000;7(2):111-19 (Pubitemid 30196848)
44. World Health Organization. Cancer Control: Knowledge into Action, WHO Guide for Effective Programmes-Palliative Care 2007: Available from: http://www.who.int/cancer/media/FINAL-Palliative%20Care%20Module.pdf
45. Brennan F. Palliative care as an international human right. J Pain Symptom Manage 2007;33(5):494-9 (Pubitemid 46669893)
46. Pergolizzi J, Boger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008;8(4):287-313
47. Ripamonti CI, Bandieri E, Roila F. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol 2011;22 Suppl. 6:vi69-77
48. Smith HS. Opioid metabolism. Mayo Clinic proceedings Mayo Clinic 2009;84(7):613-24
49. Roque IFM, Martinez-Zapata MJ, Scott-Brown M, et al. Radioisotopes for metastatic bone pain. Cochrane Database Syst Rev 2011; (7): CD003347
50. AGS Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc 2002;50(6 Suppl.):S205-24
51. Ospina M, Harstall C. Prevalence of chronic pain: an overview. Edmonton, Alberta: Alberta Heritage Foundation for Medical Research, 2002
52. Monti DA, Kunkel EJ. Management of chronic pain among elderly patients. Psychiatr Serv 1998;49(12):1537-9 (Pubitemid 28563645)
53. Forde G. Adjuvant analgesics for the treatment of neuropathic pain: evaluating efficacy and safety profiles. J Fam Pract 2007;56(2 Suppl Pain):3-12 (Pubitemid 46281113)
54. Vellucci R, Sarzi-Puttini P, Zuccaro SD, et al. Barriers to pain management: Focus on Opioid Theory Clin Drug Investig 2012;32(Suppl. 1):11-9
55. Herr K. Pain assessment strategies in older patients. J Pain 2011;12(3 Suppl 1):S3-S13
56. Barkin RL, Beckerman M, Blum SL, et al. Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult? Drugs Aging 2010;27(10):775-89